| Financial Year |
March 31 2023 |
| Monetary Funds |
222,496,621.06 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
101,561,451.37 |
| Accounts Receivable |
717,411,979.01 |
| Advances to Suppliers |
257,629,731.82 |
| Other Receivables |
14,523,008.62 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
548,032,809.95 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
758,869.82 |
| Total Current Assets |
1,977,918,869.37 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
529,556,485.99 |
| Investment Properties |
-- |
| Fixed Assetes |
213,085,731.96 |
| Under-construction Projects |
7,822,509.20 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
48,786,977.58 |
| R&D expenses |
-- |
| Goodwill |
1,169,885.78 |
| Long-Term Deferred and Prepaid Expenses |
3,413,556.06 |
| Deferred Income Tax Assets |
41,922,901.09 |
| Other Non-Current Assets |
17,782,384.30 |
| Sub-Total of Non-Current Assets |
1,063,218,103.39 |
| Total Assets |
3,041,136,972.76 |
| Short-Term Loans |
118,500,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
193,611,120.00 |
| Accounts Payable |
489,002,658.32 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
1,553,674.00 |
| Taxes Payable |
12,627,822.48 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
160,427,811.73 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
2,704,553.58 |
| Other Current Liabilities |
77,488,686.99 |
| Sub-Total of Current Liabilities |
1,160,308,765.98 |
| Long-term Loans |
30,500,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
3,542,893.59 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
93,144,705.07 |
| Total Liabilities |
1,253,453,471.05 |
| Paid-In Capital(Or Share Stock) |
385,494,593.00 |
| Capital Surplus |
277,388,251.94 |
| Surplus Reserve |
187,598,476.68 |
| LESS:Treasury Stock |
15,681,350.00 |
| Undistributed Profits |
935,742,841.80 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,787,683,501.71 |
| Owner's Equity（Stockholder's Equity） |
1,787,683,501.71 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,041,136,972.76 |
